Martínez-Martínez Sonia, Frandoloso Rafael, Gutiérrez-Martín César B, Lampreave Fermín, García-Iglesias María José, Pérez-Martínez Claudia, Rodríguez-Ferri Elías F
Section of Microbiology and Immunology, Department of Animal Health, University of León, 24007 León, Spain.
Vet Immunol Immunopathol. 2011 Nov 15;144(1-2):61-7. doi: 10.1016/j.vetimm.2011.07.002. Epub 2011 Jul 18.
Haemophilus parasuis is the etiological agent of Glässer's disease, which is characterized by fibrinous polyserositis, polyarthritis and meningitis in pigs. This study was focused on the characterization of the acute-phase response after immunization and infection of colostrum-deprived pigs with H. parasuis serovar 5, by measuring serum concentrations of three positive acute-phase proteins (APPs) (pig major acute-phase protein pig, MAP; haptoglobin, HPG; C-reactive protein, CRP) and one negative APP (apolipoprotein A-I, ApoA-I). Six experimental groups were established: a non-immunized but infected control group (CTL); two groups immunized with either a recombinant transferrin-binding protein (Tbp) A or TbpB fragment from H. parasuis Nagasaki strain (rTbpA and rTbpB, respectively); two groups immunized with native outer membrane proteins with affinity to porcine transferrin (NPAPT), one of them inoculated intramuscularly (NPAPTim) and the other intratracheally (NPAPTit), and the last group receiving a commercially available bacterin (PG). The greatest concentrations of the three positive APPs and the lowest concentration of the negative APP were detected in CTL group, as well as in those animals belonging to rTbpA or rTbpB groups that died in response to challenge. Significant differences (P<0.005) were found in these groups when comparing challenge with the following days after it. However, no significant differences were seen for the remaining vaccinated groups (NPAPTim, NPAPTit and PG), which were effectively protected against Glässer's disease. Therefore, APPs could be used as useful biomarkers for both evaluating disease progression and determining vaccination effectiveness.
副猪嗜血杆菌是猪格氏病的病原体,其特征为猪出现纤维素性多浆膜炎、多关节炎和脑膜炎。本研究聚焦于初乳缺乏仔猪经副猪嗜血杆菌血清型5免疫和感染后的急性期反应特征,通过测定三种阳性急性期蛋白(APPs)(猪主要急性期蛋白、MAP;触珠蛋白、HPG;C反应蛋白、CRP)和一种阴性APP(载脂蛋白A-I、ApoA-I)的血清浓度来进行研究。建立了六个实验组:一个未免疫但感染的对照组(CTL);两组分别用来自副猪嗜血杆菌长崎菌株的重组转铁蛋白结合蛋白(Tbp)A或TbpB片段进行免疫(分别为rTbpA和rTbpB);两组用与猪转铁蛋白有亲和力的天然外膜蛋白进行免疫(NPAPT),其中一组肌肉注射(NPAPTim),另一组气管内注射(NPAPTit),最后一组接种市售菌苗(PG)。在CTL组以及rTbpA或rTbpB组中因攻毒而死亡的动物中,检测到三种阳性APP的浓度最高,阴性APP的浓度最低。与攻毒后的后续几天相比,在这些组中发现了显著差异(P<0.005)。然而,其余接种疫苗的组(NPAPTim、NPAPTit和PG)未观察到显著差异,这些组有效预防了格氏病。因此,APPs可作为评估疾病进展和确定疫苗接种效果的有用生物标志物。